Feasibility and rationale of a novel approach in advanced ovarian cancer surgery: Bat- shaped en-bloc total peritonectomy and total hysterectomy salpingo-oophorectomy with or without rectosigmoid resection (Sarta-Bat approach)

Author(s):  
Ghanim Khatib ◽  
Sevtap Seyfettinoglu ◽  
Ahmet Baris Guzel ◽  
Umran Kucukgoz Gulec ◽  
Hakkı Unlugenc ◽  
...  
2018 ◽  
Vol 12 ◽  
Author(s):  
Victor Lago ◽  
Santiago Domingo ◽  
Luis Matute ◽  
Pablo Padilla-Iserte ◽  
Marta Gurrea

2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Antoni Llueca ◽  
◽  
Anna Serra ◽  
Maria Teresa Climent ◽  
Blanca Segarra ◽  
...  

An amendment to this paper has been published and can be accessed via the original article.


2012 ◽  
Vol 30 (15_suppl) ◽  
pp. e15568-e15568
Author(s):  
Leslie A. Garrett ◽  
Whitfield Board Growdon ◽  
David M. Boruta ◽  
Marcela G del Carmen ◽  
Anna M. Priebe ◽  
...  

e15568 Background: The efficacy of PDS for advanced ovarian cancer has recently been challenged by data suggesting equivalent clinical outcomes for neoadjuvant chemotherapy (NACT) and interval debulking surgery (IDS). The strongest known predictor of prolonged survival in either group is the ability to achieve complete resection (CR) to no residual disease. PDS that results in a CR is associated with the longest overall survival of any sequence of treatment. The aim of this study was to determine what type of surgical approach is required to successfully perform PDS. Methods: All women with newly diagnosed stage IIIC epithelial ovarian carcinoma treated at our institution from 2000 to 2010 were identified. Pathology was prospectively reviewed by a faculty gynecologic pathologist. Treatment planning was discussed and documented at our weekly multidisciplinary tumor board conference. Data was retrospectively extracted from computerized medical records. Results: 344 (86%) of 401 women underwent PDS. Optimal debulking was achieved in 278 patients (81%): 35% had CR while 46% had 0.1-1.0 cm residual disease. 56 stage IIIC pts (19%) had a suboptimal surgical outcome with ≥ 1.0 cm. Compared to those having a CR, patients with 0.1-1.0 cm residual were more likely to require splenectomy (17 v 5%; P = 0.002) and transverse colectomy (19 v 10%; P = 0.042), with comparable rates of rectosigmoid resection (41 v 39%; P = 0.712) and en bloc pelvic resection including total peritonectomy (26 v 30%; P = 0.050). Patients undergoing CR were more likely to have diaphragmatic surgery (31 v 20; P = 0.068) and lymphadenectomy (67 v 33%; P < 0.001). Conclusions: PDS is the preferred treatment of stage IIIC epithelial ovarian cancer at high-volume centers demonstrating >75% rates of optimal cytoreduction. Tumor biology may lead to the need for more aggressive upper abdominal procedures in patients with 0.1-1.0 residual. Diaphragm resection, stripping or ablation is more often required in order to achieve CR. Since subclinical macroscopic nodal metastases are often present, lymphadenectomy is also frequently performed to ensure that all possible disease has been resected.


Sign in / Sign up

Export Citation Format

Share Document